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1.1.1.1 Highlights 
 Brain activation alterations associated with cannabis use was examined 
 Changes in adults and adolescents were examined separately 
 Studies using fMRI to measure brain activation were combined meta-
analytically 
 Adult cannabis users had increased activation in frontal and temporal 
regions.  
 They also had decreased activation in striate area, insula and middle 
temporal gyrus. 
 Adolescent cannabis users had increased activation in inferior parietal 
gyrus and putamen.  
 
1. Abstract 
While numerous studies have investigated the residual effects of cannabis use on 
human brain function, results of these studies have been inconsistent. Using 
meta-analytic approaches we summarize the effects of prolonged cannabis 
exposure on human brain function as measured using task-based functional MRI 
(fMRI) across studies employing a range of cognitive activation tasks comparing 
regular cannabis users with non-users. Separate meta-analyses were carried out 
for studies investigating adult and adolescent cannabis users. Systematic 
literature search identified 20 manuscripts (13 adult and 7 adolescent studies) 
meeting study inclusion criteria. Adult analyses compared 530 cannabis users to 
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580 healthy controls while adolescent analyses compared 219 cannabis users to 
224 healthy controls.  
In adult cannabis users brain activation was increased in the superior and 
posterior transverse temporal and inferior frontal gyri and decreased in the 
striate area, insula and middle temporal gyrus. In adolescent cannabis users, 
activation was increased in the inferior parietal gyrus and putamen compared to 
healthy controls. Functional alteration in these areas may reflect compensatory 
neuroadaptive changes in cannabis users.  
2.  Keywords: Cannabis, THC, Functional magnetic resonance imaging, Meta-analysis. 
 
 
3. Introduction 
 Cannabis has been used recreationally for thousands of years (Russo, 2007) and 
is currently the world’s most used illicit drug, with around 183 million users 
globally (Unodc, 2017). Cannabis use has been associated with a number of 
adverse mental, psychological and social outcomes (Appiah-Kusi et al., 2016; 
Crippa et al., 2009; Gage et al., 2016; Goldenberg et al., 2017; Marconi et al., 
2016; Meier et al., 2012; Moore et al., 2007; Patel et al., 2016; Schoeler et al., 
2016a; Schoeler et al., 2016b; Schoeler et al., 2016c; Schoeler et al., 2016d). 
Consistent with this, acute challenge studies in humans have shown that delta-9-
tetrahydrocannabinol (THC) can induce transient psychotic and anxiety 
symptoms (Bhattacharyya et al., 2017; D'Souza et al., 2004) , as well as changes 
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to cognitive task performance(Curran et al., 2002; D'Souza et al., 2004)  and 
functional brain activation during cognitive and emotional activation 
tasks(Bhattacharyya et al., 2015; Bhattacharyya et al., 2012a; Bhattacharyya et 
al., 2012c; Bhattacharyya et al., 2009; Bhattacharyya et al., 2010; Bossong et al., 
2012a; Bossong et al., 2012b; Morrison et al., 2011; Phan et al., 2008; van Hell et 
al., 2011; van Hell et al., 2012; Winton-Brown et al., 2011). Hence, the residual 
effects of cannabis use on brain function that persist beyond the immediate acute 
intoxication effects (typically lasting for a few hours (Grotenhermen, 2003)) and 
may underlie its adverse mental, psychological and social effects are of particular 
interest. 
Animal studies have found morphological as well as neurochemical changes in 
areas rich in cannabinoid type 1 (CB1) receptors following THC exposure during 
adulthood (Colizzi et al., 2016; Heath et al., 1980; Landfield et al., 1988; Scallet et 
al., 1987), as well as changes in cognitive function following prolonged exposure 
to cannabis (Imam et al., 2017). Human studies have shown impaired cognition 
that persist beyond the acute intoxication period in both adult and adolescent 
cannabis users, particularly in the performance of memory, attention, executive 
function and learning tasks (Crane et al., 2013; Crean et al., 2011; Ganzer et al., 
2016; Lundqvist, 2005; Schoeler and Bhattacharyya, 2013; Schoeler et al., 2016a; 
Solowij et al., 2002). Human studies have also shown impaired cognition 
(executive functioning, processing speed, attention and memory) in adolescent 
cannabis users when compared to controls (Jacobus et al., 2009; Jacobus and 
Tapert, 2014), with suggestion of this impairment being greater than in adult 
users particularly in the domains of learning and memory (Schweinsburg et al., 
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2008a). Meta-analysis of cognitive task performance in current users found a 
significant negative effect on global cognitive task performance as well as in 
most cognitive domains tested (executive functioning, attention, memory, motor 
control, reaction time) while an analysis of currently abstinent users found no 
significant effect either on global cognitive task performance or the specific 
domains assessed (Schreiner and Dunn, 2012). Consistent with these results, 
studies investigating structural changes in whole-brain architecture have 
reported both changes in grey and white matter density as well as lack of 
differences when compared to control groups as reviewed here (Batalla et al., 
2013). In contrast, studies employing a region of interest (ROI) analysis 
approach have reported decreased volume in the hippocampus (Matochik et al., 
2005) that appeared to correlate with cannabis use levels (Cousijn et al., 2012; 
Yücel et al., 2008) and persisted even after a prolonged period of abstinence 
(Ashtari et al., 2011). However, reduced hippocampal volume has not been 
consistently reported in adult (Tzilos et al., 2005) or adolescent (Silveri et al., 
2016) cannabis users. 
Several systematic (Batalla et al., 2013; Martin-Santos et al., 2010) and narrative 
(Bhattacharyya et al., 2012b; Bhattacharyya and Sendt, 2012; Chang and 
Chronicle, 2007; Gonzalez, 2007; Quickfall and Crockford, 2006) reviews have 
summarized the effects of regular cannabis use on human brain function using 
data from functional magnetic resonance imaging (fMRI) studies. Collectively, 
these results suggest a wide pattern of brain function alteration associated with 
cannabis use in humans. However, the results of these studies have been 
inconsistent and no clear picture has emerged as yet. A number of different 
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methodological factors may underlie the heterogeneity in these results, such as 
small sample sizes, heterogeneous populations including in their length of 
cannabis exposure as well as neuroimaging methods employed. Meta-analytic 
approaches allow the statistical integration of results from multiple individual 
studies that on their own may be insufficiently powered to detect the effect of 
cannabis exposure on brain function. To our knowledge, such an approach has 
not been applied as yet to investigate the effects of cannabis exposure on human 
brain function, but collectively have greater statistical power to reliably and 
robustly detect group differences. 
Another important consideration is that previous fMRI studies have employed a 
wide range of cognitive activation paradigms that engage various cognitive 
processes (Batalla et al., 2013; Martin-Santos et al., 2010) shown to be affected 
by cannabis use. Studies employing specific cognitive paradigms in conjunction 
with fMRI are likely to demonstrate altered function in brain substrates or 
networks that play a central role in the cognitive processes engaged by the 
paradigm being used. However, the effects of cannabis are not likely to be limited 
to only those cognitive processes or brain regions that subserve those processes 
that are being investigated in a particular study.  Instead, the effects of cannabis 
use on brain function are very likely to depend on (among a number of other 
factors) distribution of the main receptor targets (for example the CB1 receptor) 
(Pertwee, 2006) for the cannabinoids present in cannabis such as delta-9-
tetrahydrocannabinol. It is well-recognised that one of the main cannabinoid 
receptors, the CB1 receptor, is fairly ubiquitous in distribution in the brain 
(Iversen, 2003). Therefore, brain function alterations associated with cannabis 
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use are likely to be distributed throughout the brain, consistent with the 
distribution of CB1 in the brain, as shown by the association between acute 
effects of THC and central CB1 availability (Bhattacharyya et al., 2017). By 
allowing us to quantitatively summarize whole-brain analysis fMRI data from 
studies employing a diverse array of cognitive activation paradigms, the meta-
analytic approach provides a robust method to address the broader question as 
to where in the brain are there robust functional alterations associated with 
cannabis use, that are independent of specific cognitive processes of interest?  
 To our knowledge, such an approach has not been applied as yet to investigate 
the effects of cannabis exposure on human brain function. Hence, we have 
investigated this focusing specifically on the non-acute or residual effects of 
repeated cannabis exposure on human brain function. Articulation of a precise 
definition of the timescale beyond which any effects of cannabis that persist may 
be described as non-acute effects and one that is consistently used by studies in 
the field is challenging. However previous reviews in the field have sought to 
define non-acute effects as those that persist after several hours of abstinence 
(Crane et al., 2013; Crean et al., 2011) . Consistent with this approach and 
mindful of the fact that acute intoxication effects following use of cannabis by the 
inhalation route (often the typical route of use) lasts usually around 3 hours 
(Grotenhermen, 2003) , for the purpose of this meta-analysis we have defined 
non-acute effects as those that last beyond several hours of abstinence and are 
not observed following experimental cannabinoid challenge. However, as an 
overarching strategy, we have adopted a pragmatic approach in this regard in 
order to optimize the number of studies that are suitable for inclusion in our 
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analyses, given that not all studies have consistently reported this. We aimed to 
quantify effects across studies employing a diverse array of cognitive tasks, 
rather than a narrow set of conceptually related tasks, with a view to identifying 
the distributed network of brain regions showing significant neurophysiological 
alteration in those regularly exposed to cannabis compared to non-users. In 
order to summarize the current literature and identify convergent findings, we 
therefore conducted a systematic literature search to identify studies that have 
investigated the effects of long-term cannabis use on human brain function using 
fMRI techniques. 
Previous studies have shown that cannabis use is generally associated with an 
attenuation of activation in the brain regions typically engaged by the cognitive 
paradigm employed (Martin-Santos et al., 2010). On the other hand, cannabis use 
has also been associated with increased engagement of brain regions such as the 
posterior cingulate, medial prefrontal and the inferior parietal cortex (Abdullaev 
et al., 2010; Chang and Chronicle, 2007; Chang et al., 2006; Gruber et al., 2012; 
Kanayama et al., 2004; Martin-Santos et al., 2010; Nestor et al., 2008), which 
together with the medial temporal cortex are part of the default mode network 
(DMN) (Buckner et al., 2008). In healthy individuals, regions within this network 
are deactivated or have an attenuation of activation while performing a cognitive 
task that involves focusing of attention (Fox et al., 2009b; Raichle et al., 2001) 
and activation in this network is anti-correlated with task-positive activation 
(Fox et al., 2006). Cannabis use has also been associated with altered activation 
of brain regions such as the dorsolateral prefrontal and posterior parietal cortex 
and intraparietal sulcus/ superior parietal lobule (Bolla et al., 2005; Eldreth et 
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al., 2004; Jager et al., 2006; Schweinsburg et al., 2008a; Sevy et al., 2008; Tapert 
et al., 2007). Collectively, these regions are also known as the central executive 
network (CEN) and that are thought to subserve higher order cognitive functions 
such as the control of attention, working memory, executive function (Seeley et 
al., 2007; Sridharan et al., 2008). Altered activation have also been reported in 
cannabis users commonly in the amygdala, caudate, insula, orbitofrontal and 
anterior cingulate cortices (Block et al., 2000; Gruber et al., 2009; Harding et al., 
2012; Hester et al., 2009; van Hell et al., 2010) that are part of the salience 
network (SN) (Menon, 2011; Seeley et al., 2007). All of these regions also have a 
high density of the main central CB1 receptor (Elphick and Egertova, 2001; Glass 
et al., 1997). Although, cannabinoid challenge has been found to modulate 
various components of these networks (Batalla et al., 2014; Bhattacharyya et al., 
2012b) and their connectivity(Bhattacharyya et al., 2015; Gorka et al., 2016) 
acutely, the precise association of regular cannabis use with altered functioning 
of these large-scale brain networks is much less clear (Batalla et al., 2013; 
Wijayendran et al., 2016).  
As we pooled data from studies employing a diverse array of cognitive tasks that 
may differentally engage cognitive processes and brain regions, we hypothesized 
that the present meta-analysis would specifically identify a core network of brain 
regions as being differentially activated in cannabis users compared to controls.  
We specifically hypothesized that robust differences in activation between 
cannabis users and controls would be detected in brain regions that are part of 
the CEN, SN and DMN networks.  
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Adolescence represents a critical period of vulnerability to exogenous insults 
when many developmental processes including brain development and binding 
affinity of CB1 receptors, the main target of cannabinoids, are in a state of flux 
before attaining maturity in early adulthood (Andersen, 2003; Belue et al., 1995; 
Rice and Barone, 2000; Spear, 2007). Both animal (Belue et al., 1995; Verdurand 
et al., 2011) and human (Biegon and Kerman, 2001; Glass et al., 1997; Mato et al., 
2003), studies indicate a progressive increase in CB1 receptor density from early 
life into adolescence, before stabilising in adulthood (Belue et al., 1995). 
Furthermore, evidence from animal studies has also emerged that exposure to 
the effects of  THC during adolescence may be associated with altered 
maturation of the endocannabinoid system leading to impairments in 
endocannabinoid signaling and long-term depression as well as cognition in 
adulthood (Rubino et al., 2015), consistent with independent evidence of 
reduced compensatory CB1 downregulation in adolescent compared to adult 
rodents following experimentally induced cannabinoid exposure (Dalton and 
Zavitsanou, 2010). Preclinical research has also shown adolescence to be a 
period of greater sensitivity to cannabinoids compared to adults in terms of 
greater impairment in certain cognitive tasks (object recognition memory, 
spatial memory, prepulse inhibition, operant behavioural task) as well as altered 
hippocampal protein expression profile (Quinn et al., 2008; Schneider and Koch, 
2003), though other studies have shown greater impairment (in spatial learning 
and novel object recognition) in adults (Acheson et al., 2011; Fox et al., 2009a). 
In line with this preclinical evidence of differential sensitivity, a human study has 
also demonstrated age-related differential sensitivity to the subjective, cognitive 
(memory and inhibitory processing), physiological and psychotomimetic effects 
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of a single dose of cannabis under experimental conditions in male cannabis 
users, without a clear pattern emerging of greater vulnerability of either 
adolescent or adult users (Mokrysz et al., 2016). Nevertheless, as available 
evidence broadly suggests differential sensitivity of adolescent versus adult 
users, we have carried out separate meta-analyses focusing on studies in adult 
and adolescent cannabis users. Meta-analyses based on coordinates from altered 
brain activation results and their associated statistical values were used to 
determine changes in activation across all studies that meet our criteria. We 
hypothesized that adult and adolescent cannabis users would show distinctly 
different patterns of functional brain activation compared to healthy controls.  
 
4. Methods 
4.1 Search strategy and selection of studies. 
We conducted a systematic search of published literature in the publication 
database Pubmed following the Cochrane Handbook (JPT, 2011) and the MOOSE 
guidelines (Stroup et al., 2000) employing two categories of search terms: 1) 
Cannabis: cannabis, marijuana, marihuana, THC, tetrahydrocannabinol and 2) 
Neuroimaging technique: fMRI, imaging, functional activation, BOLD. Boolean 
Operators were used to combine the two categories. The search was limited to 
human studies and run through the titles and abstracts. An initial Pubmed search 
was completed on the 21/10/2015, which was finally repeated again on the 
13/12/2017.. To identify further relevant publications, reference lists were 
screened from included manuscripts and published reviews. 
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Only published peer-reviewed manuscripts reported in English language 
journals that satisfied the following inclusion criteria were selected: 
 Original peer-reviewed data-based publication. 
 Compared habitual otherwise healthy cannabis users (>50 times of 
lifetime use, as indexed by self-reported number of occasions of cannabis 
use over the person’s lifetime), to healthy controls who were not habitual 
cannabis-users (with < 50 times of lifetime  cannabis use).   
 Reported results using whole-brain imaging analysis. 
 Used a cognitive or emotional activation task that did not involve 
cannabis-related stimuli.  
 
The initial search in October 2015 identified 598 manuscripts which were 
screened for inclusion into the study (figure 1). No additional studies meeting 
study inclusion criteria were identified in a final repeat search performed on the 
13/12/2017.  
4.2 Data Extraction 
Data was extracted in to a database with the variables of interest retrieved from 
the included studies after establishing that whole brain analysis results were 
reported. Coordinates of significant peaks were extracted along with their t-
statistic. If a t-statistic was not reported, this was computed from a z-value or p-
value, using a converter (www.sdmproject.com/utilities/?show=Statistics) 
provided with the software used for meta-analysis, Seed based d- Mapping (SDM, 
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formally signed differential mapping) (Sdmproject.com, 2017). If no statistic 
value was reported a positive or negative peak was indicated with a ‘p’ or ‘n’ 
respectively as per established approaches (Radua et al., 2012). Studies that had 
no significant peaks were also included. 
Each separately reported contrast of interest relative to a control condition 
within a published manuscript was treated as a separate study. For example, a 
study comparing cannabis users with non-users while performing a gambling 
task during fMRI might have reported both the ‘win’ and ‘lose’ conditions each 
compared separately with the control condition. In this case, the ‘win’ and ‘lose’ 
conditions would have been considered as two separate studies for the purposes 
of the meta-analysis. Hereafter, each of these separate contrasts of interest 
included in the meta-analysis as a separate study are referred to as such within 
the methods section. As per established protocol (Radua et al., 2012) a text file 
was created for each study, including the coordinates reported, t-value (positive 
or negative, such that activation increased in cannabis users was reported as 
positive and increased in healthy controls as negative), and the number of 
participants for each group. Information as to the specific brain template e.g. 
Montreal Neurological Institute (MNI) or Talairach template used in reporting 
the brain activation coordinates in the study was included with this study 
specific text file. 
Quality assessment of each study was completed using criteria previously used 
for fMRI studies (Radua et al., 2015). However, we did not exclude any of the 
studies based on this quality assessment, but have reported the results of the 
quality assessment as part of supplementary material (supplementary table 4).    
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4.3 Data Analysis 
Meta-analysis was carried out using seed-based d mapping (SDM) 
(Sdmproject.com, 2017), the methods of which have been describe in detail 
elsewhere (Radua et al., 2014) and applied in a number of meta-analyses of fMRI 
data (Alegria et al., 2016; Norman et al., 2016; Rubia et al., 2014; Scognamiglio 
and Houenou, 2014). For voxels containing a peak, the unbiased effect-size and 
variance was computed using standard formulae (Hedges and Olkin, 1985). For 
the rest of the voxels, the effect-size was estimated by assigning an effect-size to 
each voxel based on its distance to nearby peaks using a 20 mm full-width-at-
half-maximum non-normalized Gaussian kernel (Radua and Mataix-Cols, 2009). 
In this method, the kernel was multiplied by the effect-size of the peak. When a 
voxel was assigned a value from more than one coordinate, the value was 
averaged weighting by the square of the distance to each close peak. Bias from 
one study reporting many close coordinates was limited by employing a study 
value maximum. Both positive and negative activations were modelled on the 
same map. If the t values of the peak coordinates were unknown, SDM conducted 
a threshold-based imputation of effect-size, which consisted of estimating the 
mean-effect-size of peaks from studies reporting t values, separately for each 
type of significance threshold. These processes were fully automated within the 
SDM software.  SDM uses peak coordinates and their associated statistical values 
to create individual effect-size brain maps for each study and implements a 
random-effects model to meta-analytically combine the data from each study, by 
weighting each study with the inverse of the sum of its variance plus the 
between-study variance as obtained by the DerSimonian-Laird estimator 
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(DerSimonian and Laird, 1986), which is statistically comparable to the 
restricted maximum likelihood (Viechtbauer, 2005). Heterogeneity Q statistic is 
assessed in terms of a chi-square distribution and reported after conversion to 
standard z values.  
For the present meta-analyses, all maps created as above from each study were 
then included in a meta-analytic Seed-based d map. A null distribution of the 
meta-analytic values was created to test which voxels had more studies 
reporting difference of activation around them than by chance, performed by 
monte-carlo randomizations of coordinates. Twenty permutations have been 
used, as this number has been shown to yield highly stable results (Radua et al., 
2012) . Results have been thresholded to ensure voxel threshold = p<0.005, peak 
height threshold: peak SDM-Z < 1, and a cluster-size threshold of clusters ≥ 10 
voxels.  
Heterogeneity Q statistic was assessed in terms of a chi-square distribution and 
reported after conversion to standard z values. Jack-knife sensitivity analysis 
was completed on both analyses, and visually inspected to assess heterogeneity. 
This method repeats the meta-analysis as many times as the number of studies 
removing each study in turn from one run of the analysis. Funnel plots were 
created for each cluster, in order to perform Egger’s test and assess publication 
bias (Sedgwick and Marston, 2015) as a result of a greater likelihood of 
publication (and therefore of inclusion in the meta-analysis) of studies with 
statistically significant results than those with non-significant results. 
AC
CE
PT
ED
 M
AN
US
CR
IPT
G. Blest-Hopley, V. Giampietro & S. Bhattacharyya 
 
16 
Co-ordinates of cluster peaks and cluster extent were then reported using MNI 
coordinates. Each cluster peak was examined using a human brain atlas in order 
to visually inspect the peak region (Mai et al., 2008).  
4.4 Sub-group and regression analysis 
To investigate whether differential task performance was influencing group 
differences in brain activation, we performed a sub-group analysis, including 
only studies that reported no significant group difference in task performance. 
Sub-group analysis for adult studies to investigate the effect of differential task 
performance included all studies from the main analysis excluding three studies 
(Abdullaev et al., 2010; Sneider et al., 2013; Wesley et al., 2011), making up a 
total of six comparisons. The equivalent sub-group analysis for adolescent 
studies excluded only one study from the main analysis (Behan et al., 2014). 
Effect of comorbid tobacco, alcohol or other drug use on group differences 
between the cannabis user and control groups was investigated by carrying out a 
sub-group analysis, including only studies which had matched groups for use of 
these substances. This was only completed for adult studies as all of the 
adolescent studies reported some difference in alcohol, tobacco or drug use 
between groups. Five studies, with 17 different comparisons were used in the 
sub-group analysis of adult studies (Abdullaev et al., 2010; Heitzeg et al., 2015; 
Nestor et al., 2010; Nestor et al., 2008; Smith et al., 2011) to investigate the effect 
of comorbid tobacco, alcohol or other drug use. All other studies reported 
significant difference in at least one of the substances of interest to the sub-
group analysis, except one which was not included in sub-group analysis as it did 
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not provide any information on difference in tobacco use (Kanayama et al., 
2004). 
A further sub-group analysis, including only studies that employed a memory 
task as a cognitive activation paradigm for fMRI, was carried out using identical 
approaches as in the main data analysis, to investigate the effects of cannabis use 
over tasks engaging similar cognitive processes. Due to the limited number of 
studies that employed related cognitive activation tasks that could be grouped in 
a meaningful way as being related, we were only able to carry this out for studies 
employing paradigms involving memory processing in adults. For adolescent 
studies, a similar search led to only 2 studies (Schweinsburg et al., 2008b; 
Schweinsburg et al., 2011), which was not deemed enough for a meta-analysis.  
Meta–regression analyses were carried out using approaches described 
previously (Radua and Mataix-Cols, 2009) to investigate association with level of 
life-time cannabis use and gender, in light of considerable variation in both 
cannabis use and gender distribution across the included studies . We quantified 
life-time cannabis use employing reported data to arrive at a cannabis use 
measure that was broadly comparable across studies. Where no life-time 
cannabis data was reported, this was estimated using information on number of 
instances of use per week/ month and multiplying that with lifetime duration of 
use reported in the study. Where any of these measures have been reported in 
the published manuscript as a range for the group, the median value was used. 
Results of all meta-regression and sub-group analyses have been thresholded to 
ensure voxel threshold = p<0.005, peak height threshold: peak SDM-Z < 1, and a 
cluster-size threshold of clusters ≥ 10 voxels.  
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A further meta-regression was carried out to investigate the association with age 
of onset of cannabis use in the studies in adults. As information on age of onset of 
cannabis use was not available for all studies that were included (8 out of 13 
studies reported age of onset), for this meta-regression we only included studies 
with this information. Meta-regression was completed using the mean values for 
age of cannabis use onset taken from the manuscript or computed using 
available data. If the means were reported separately for males and females, 
these were recalculated to arrive at one mean for the study. 
 
 
5.  Results 
5.1 Publications  
A final list of 20 manuscripts employing task-base fMRI were found to meet 
study inclusion criteria (Abdullaev et al., 2010; Acheson et al., 2015; Behan et al., 
2014; Chang et al., 2006; Cousijn et al., 2013; Gruber et al., 2009; Heitzeg et al., 
2015; Jager et al., 2013; Kanayama et al., 2004; King et al., 2011; Lopez-Larson et 
al., 2012; Nestor et al., 2010; Nestor et al., 2008; Schweinsburg et al., 2008b; 
Schweinsburg et al., 2011; Smith et al., 2011; Sneider et al., 2013; Tapert et al., 
2007; van Hell et al., 2010; Wesley et al., 2011). Figure 1 shows the PRISMA 
flowchart (Moher et al., 2009), with reasons for exclusion of studies. Thirteen of 
these investigated adults, (Table 1), and seven investigated adolescent cannabis 
users, (Table 2). Each separate contrast of interest that was reported comparing 
users to controls within these 20 manuscripts was considered as a separate 
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study for the purposes of the meta-analysis (as described earlier in the Methods 
section), giving a total of 43 studies (of which 10 reported no significant results), 
31 investigating adults (seven with no significant results), and 11 investigating 
adolescents (three with no significant results). Adult studies included 
participants between the age range of 17-55 years (based on 7 out of a total of 13 
studies), while adolescent studies had a participant age range of 13-19 years. 
The adult analysis compared 530 cannabis users to 580 healthy controls. The 
adolescent analysis compared 219 cannabis users to 224 healthy controls.  
Studies in adults included cognitive paradigms that engaged memory (n=3), 
attentional processing (n=2), monetary incentive delay (n=2), emotional 
processing (n=2), gambling (n=2), inhibitory processing (n=1) and checker 
board (n=1) tasks. Studies in adolescents included cognitive paradigms that 
engaged memory (n=2), inhibitory processing (n=2), gambling (n=1), monetary 
incentive (n=1) and finger tapping (n=1) tasks. 
5.2 Effects on the adult brain  
All cannabis-using groups were reported to have used cannabis between at least 
one day per week to 6-7 days per week. Controls included in these studies 
reported cannabis use as not greater than 50 times over life-time (Table 1).  
In adult cannabis users there were three areas of significantly greater activation 
in cannabis users compared to controls (Figure 2 and Table 1): left superior 
temporal gyrus (extending to the angular gyrus and middle temporal gyrus), 
right inferior frontal gyrus (extending to both opercular and triangular parts) 
and left posterior transverse temporal gyrus (extending to the superior temporal 
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gyrus). Four clusters showed significantly decreased activation in cannabis users 
compared to controls: left striate area (extending to the inferior, superior, and 
middle occipital gyrus, calcarine fissure, lingual gyrus and cuneus), left area 
piriformis insulae (extending to the insula, lenticular nucleus and putamen) and 
two clusters in the right middle frontal gyrus (including the precentral gyrus, 
middle and superior frontal gyrus) (Table 3). 
 
5.3 Effects on the adolescent brain 
In adolescent studies there were two clusters of significantly greater activation 
in cannabis users compared to controls: the right inferior parietal gyrus, 
(extending to the superior parietal gyrus and angular gyrus), and right putamen 
(extending to the striatum and insula) (Figure 2, Table 3). 
 
5.4 Sensitivity, Heterogeneity and Publication bias 
Jack-knife sensitivity analyses for both meta-analyses were completed and 
inspected. For the adult meta-analysis, inspection of the jack-knife sensitivity 
analyses showed that all seven clusters survived in the 74% of the repeat 
analyses. However, a small number of studies did appear to be having a large 
influence on different positive clusters, suggesting heterogeneity in the analyses. 
Funnel plots were created and examined for each cluster and Egger’s tests 
performed to look for publication bias. All but one was found to show no sign of 
significance for bias. The activation cluster (cannabis users > controls) in the 
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superior temporal gyrus (-52, -60, 30) had a strong trend toward significance 
(p=0.054) in the Egger’s test suggesting potential publication bias.   
For the adolescent meta-analysis, inspection of the jack-knife sensitivity analyses 
showed that for 64% of outputs there was no change in the clusters reported in 
the overall results. However, two pairs of studies each appeared to be 
contributing to the two positive clusters, respectively. While this may suggest 
heterogeneity in the analyses, this may also be due to only a limited number of 
studies being available for use in the analysis. Funnel plots were created and 
examined for significant clusters, and Egger’s test was performed which was 
non-significant for one peak (right inferior parietal gyrus, 46,-46,50; p= 0.283), 
and significant at trend level for the second peak (right putamen, 28, 14, -2; 
p=0.072) suggesting potential publication bias.  
5.5 Sub-group analyses 
As stated before, we investigated whether differential task performance was 
influencing group differences in brain activation by performing a sub-group 
analysis including only studies that reported no significant group difference in 
task performance. Results from this analysis including only adult studies 
(Supplementary Table 1), showed that cannabis users had significantly greater 
activation compared to controls in the posterior transverse temporal gyrus and 
the anterior lobe of the cerebellum, but less activation than controls in the 
middle occipital gyrus, postcentral gyrus, insula and middle frontal gyrus. This 
indicated that when only studies that reported no significant group difference in 
task performance were considered, of the 3 clusters of greater activation in our 
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meta-analysis of all adult studies of cannabis users compared to controls 
(reported in 3.2), the posterior transverse temporal gyrus was still significant, 
while the two clusters in the superior temporal and inferior frontal gyri, were no 
longer significant. In contrast, all four clusters of decreased activation in 
cannabis users that were present in the meta-analysis of all adult studies 
(reported in 3.2) persisted in the sub-group analysis. 
For the equivalent sub-group analysis of adolescent studies including only 
studies with no difference in task performance, clusters of significantly greater 
activation in cannabis users from the complete group analysis (reported in 3.3) 
were essentially unchanged (Supplementary Table 2). 
For the sub-group analysis focusing on the effects of tobacco, alcohol and other 
drug use as possible confounders, we carried out analyses including only studies, 
which had matched groups for use of these substances. Results of this analysis 
for the adult studies (Supplementary Table 3)  revealed that cannabis users had 
significantly greater activation compared to controls in the inferior and superior 
frontal gyri. This indicated that of the three clusters showing significantly greater 
activation in cannabis users compared to controls in the meta-analysis of all 
adult studies (reported in 3.2), only the inferior frontal gyrus remained 
significant in the sub-group analysis. For the opposing contrast, a superior 
temporal gyrus cluster on the right side showed decreased activation in cannabis 
users relative to controls. Therefore, none of the four clusters of decreased 
activation in cannabis users compared to controls that were present in the meta-
analysis of all adult studies (reported in 3.2) persisted in the sub-group analysis. 
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An equivalent sub-group analysis was not completed for adolescent studies as all 
the studies reported some difference in other substance use.  
A further sub-group analysis investigating adult studies using only memory-
based fMRI tasks included 3 manuscripts investigating adult participants 
(Kanayama et al., 2004; Nestor et al., 2008; Sneider et al., 2013). The total 
number of separate contrasts of interest from all manuscripts was five  and 
compared 46 cannabis users to 45 healthy controls. This analysis revealed 
decreased activation in cannabis users compared to controls in the right 
precentral, postcentral and inferior frontal gyri and in the precuneus.   
 
5.6 Meta-regression analyses 
Meta-regression analysis with lifetime cannabis use levels suggested an 
association between level of cannabis use and activation across a network of 
brain regions. In the lingual and superior temporal gyri, hippocampus and 
precuneus, higher levels of cannabis use was associated with greater activation, 
while in the insula, cingulate and cerebellum, lower levels of use was associated 
with greater activation levels in adult cannabis users. In contrast, in adolescent 
cannabis users, higher level of use was associated with greater activation in the 
caudate nucleus.  
Meta-regression analysis with gender suggested an association between the 
number of female users and activation across a network of brain regions. In the 
superior temporal, superior and inferior frontal gyri as well as in the caudate 
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nucleus, higher number of female participants in the cannabis user group was 
associated with greater activation, while lower number of female participants 
was associated with greater activation bilaterally in the middle frontal gyrus in 
adult cannabis users. In contrast, in adolescent cannabis users, lower number of 
females was associated with greater activation in the caudate nucleus. 
For the meta-regression analyses to examine the association with age of onset of 
cannabis use in adult users, out of 8 studies (Abdullaev et al., 2010; Chang et al., 
2006; Gruber et al., 2009; King et al., 2011; Nestor et al., 2010; Nestor et al., 
2008; Sneider et al., 2013; Wesley et al., 2011) where it was possible to obtain a 
mean age of onset of cannabis use, there were a total of 22 separate contrasts of 
interest. A total of 322 adult cannabis users were compared to 339 healthy 
controls for the meta-regression (Supplementary Table 6). Activation was 
increased in later cannabis use onset users compared to earlier onset cannabis 
users in the posterior lobe of cerebellum and middle frontal gyrus on the right 
side and in the left superior parietal lobule. Earlier onset cannabis users had 
increased activation compared to later onset cannabis users in the right medial 
frontal gyrus and the left posterior lobe of cerebellum.  
 
 
6. Discussion 
We carried out two complementary meta-analyses of all fMRI studies that 
compared cannabis users with non-using controls separately in adolescents and 
adults using a whole-brain analysis image analysis approach. We investigated 
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adult and adolescent users separately to eliminate developmental differences 
and in light of evidence that adolescence is a time of greater vulnerability to the 
effects of cannabis use.  
Our results show that adult users had greater functional brain activation in three 
regions, the left superior temporal gyrus (STG) extending to the angular gyrus 
and middle temporal gyrus, right inferior frontal gyrus (IFG) extending to both 
opercular and triangular parts and left posterior transverse temporal gyrus 
(PTTG) extending to the superior temporal gyrus. Jack-knife sensitivity analyses 
showed that two of these clusters of altered brain function in adult cannabis 
users with peaks in the right IFG and the left PPTG were fairly robust and also 
were not susceptible to publication bias, as evident from the results of Egger’s 
test. On the other hand, post-analysis assessment of peak stability and reliability 
revealed that the largest cluster of difference with peak in the left STG, was 
produced by a limited number of studies, such that this difference was likely to 
reflect publication bias. Adult cannabis users showed lower functional brain 
activation compared to controls in four regions, the left striate area extending to 
the inferior, superior, and middle occipital gyrus, calcarine fissure, lingual gyrus 
and cuneus, the left area piriformis insulae extending to the insula, lenticular 
nucleus and putamen, and two adjacent clusters in the right middle frontal gyrus 
one extending to the precentral gyrus, and the other extending to the superior 
frontal gyrus, one a bit more anterior to the other. Jack-knife sensitivity analyses 
suggested that all four clusters were reasonably stable and were also not 
susceptible to publication bias. Consistent with our hypotheses, we observed 
changes in brain activation associated with cannabis use in regions that are part 
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of the DMN, CEN and SN. Meta-analysis of the studies in adolescents showed only 
greater activation in adolescent cannabis users compared to controls, in 
components of the DMN and SN. Although, the larger cluster of altered activation 
in the right inferior parietal gyrus extending to the superior parietal gyrus and 
angular gyrus was found to be not susceptible to publication bias, jack-knife 
analysis suggested that this cluster was produced by a limited number of studies 
reflecting considerable heterogeneity. In contrast, the second cluster of altered 
activation with peak in the right putamen extending to the striatum and insula 
had a similar result in the jack-knife analysis as well as the parietal cluster, but 
Egger’s test results approaching significance. Results of sub-group analyses, 
where this was possible, to account for the effects of differential task 
performance and use of other drugs and alcohol suggested that perhaps the 
adolescent meta-analysis results may have been less affected by these 
confounders. The relatively modest number of studies used in this analysis, as 
well as heterogeneity in the study paradigms employed in these studies may 
underlie instability in these results. Although we carried out sub-group analysis 
using only studies that used memory tasks for cognitive activation, this did not 
identify differences between adult cannabis users and controls. This may reflect 
limited power to detect differences as there were only 3 studies that met 
inclusion criteria for this analysis. A similar sub-group analysis with studies in 
adolescents was not possible as only two studies were available that used 
comparable cognitive paradigms. While one needs to be cautious in terms of 
interpretation of the results of the meta-regression analyses, they give an 
indication as to the brain regions where the effects of cannabis use may indicate 
dose-responsiveness as well as differential sensitivity moderated by gender and 
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age of onset of cannabis use.  In particular, in the right middle frontal gyrus 
where adult cannabis users had lower functional activation compared to healthy 
controls, earlier onset of cannabis use in adults seems to be associated with a 
greater reduction in activation compared to later onset cannabis users. 
Collectively, our results are consistent with a recent systematic review of 
neurofunctional effects of cannabis use following a period of abstinence from 
cannabis use of a least 14 days, wherein the authors reported consistent change 
in prefrontal, temporal and occipital regions, (Ganzer et al., 2016).  
These results are to be considered in light of a number of limitations. We were 
unable to include a substantial number of identified studies as they had only 
reported the results of region of interest (ROI) analyses (Carey et al., 2015; 
Gruber et al., 2012; Harding et al., 2012; Hester et al., 2009; Jager et al., 2010; 
Jager et al., 2006; Jager et al., 2007; Pillay et al., 2008; Pillay et al., 2004; Roser et 
al., 2012; Sagar et al., 2015; Spechler et al., 2015; Zimmermann et al., 2017), 
focusing on areas relevant to the specific task used or of interest in light of 
previously hypothesized change in cannabis users. Of the results reported in 
these manuscripts, the two studies focusing on changes in adolescent cannabis 
users reported greater activation in cannabis users in task-related areas (left 
superior parietal cortex; inferior frontal gyrus; dorsolateral prefrontal cortex; 
anterior cingulate cortex; right and left amygdala; right middle temporal gyrus) 
and no areas of decreased activation (Jager et al., 2010; Spechler et al., 2015), in 
line with our findings. In the two studies that investigated the effect of age of 
initiation of cannabis use which we were unable to include in our analyses, onset 
of use before the age of 16 was shown to be associated with a greater difference 
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in brain activity in the left anterior cingulate (Sagar et al., 2015) compared with 
controls and increased activation in the middle part of the right cingulate gyrus 
compared to those with a later onset of use (Gruber et al., 2012). While 
consistent with the idea that cannabis use during early adolescence is associated 
with greater effect on brain function than later use, this may also reflect 
differences due to higher total use in those who started use earlier compared to 
those who started later, as both of these studies investigated adult populations. 
In contrast, we found earlier onset of cannabis use in adults being associated 
with differential activation compared to later onset users in a different set of 
brain regions than those identified by these studies (Gruber et al., 2012; Sagar et 
al., 2015) . However, it is worth noting that our study was not designed to 
systematically investigate this issue. 
In the meta-analysis in adults, we found decreased activation in the cuneus in 
cannabis users consistent with results of the study by Roser and colleagues 
(Roser et al., 2012) who employed an ROI analysis approach. Some other ROI-
based studies have reported increased activation in the cingulate (Gruber et al., 
2012; Roser et al., 2012), while others reported an opposite effect (Carey et al., 
2015). Greater functional brain activation (in the left superior parietal cortex; 
inferior frontal gyrus; medial orbitofrontal cortex; precentral/ dorsolateral 
prefrontal cortex; striatum; hippocampus; cuneus and anterior cingulate cortex) 
was found by a number of the ROI-based studies (Gruber et al., 2012; Hester et 
al., 2009; Jager et al., 2010; Roser et al., 2012; Zimmermann et al., 2017). Some 
found no significant differences between groups (Cousijn et al., 2014; Harding et 
al., 2012; Jager et al., 2010; Jager et al., 2006; Spechler et al., 2015) while others 
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found only decreased activation (in the hippocampus and parahippocampal 
gyrus; inferior temporal gyrus; anterior and mid-cingulate cortex; thalamus; 
inferior and superior parietal lobule; putamen; postcentral gyrus and 
supramarginal gyrus) compared to controls, (Carey et al., 2015; Jager et al., 2007; 
Pillay et al., 2008; Pillay et al., 2004; Sagar et al., 2015). However, as these studies 
restricted their analyses to only certain brain regions, they were very likely to 
have missed any alterations in brain activation in cannabis users outside of those 
brain regions. Task performance by cannabis users was found to be not 
significantly different to control participants in the majority of the studies, with 
only 5 studies (Abdullaev et al., 2010; Behan et al., 2014; Nestor et al., 2010; 
Sneider et al., 2013; Wesley et al., 2011) reporting any difference during a range 
of different tasks (attention, Go/NoGo, monetary incentive delay, water maze 
and gambling tasks). Hence, observed differences in brain activation could 
arguably suggest neuroadaptive changes to maintain normal function. However, 
greater differences were reported in activation between groups performing the 
same task at two levels of difficulty, such that greater difference was seen in the 
more difficult version of the task (King et al., 2011).  
One important issue that needs to be highlighted is that the results of our 
separate meta-analyses in adults and adolescents are not directly comparable in 
terms of differences in the pattern of altered activation associated with cannabis 
use in these two age groups, distinct though they are. This is because we did not 
directly compare these two groups in light of the limited number of studies that 
have compared these two age groups directly to allow a meaningful integration 
of data using a meta-analytic approach. Another caveat relates to the modest 
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number of studies using similar or comparable cognitive activation paradigms in 
the two age groups, which further limits firm inferences from being drawn from 
any comparison. Nevertheless, it is worth pointing out some of the similarities 
and differences between the adult and adolescent meta-analyses.  We found no 
areas of decreased activation in adolescent cannabis users compared to healthy 
controls, while a number of regions of decreased activation were found in the 
adult cannabis users relative to the healthy controls. While this may reflect 
greater total dose of cannabis that adult users may have been exposed to 
compared to adolescent users, whether they may also relate to differences in 
alcohol, nicotine and other drug use, differences in the duration of abstinence 
before image acquisition or a reflection of sample power issues (with fewer 
studies in the adolescent meta-analysis) is unclear. However, one cannot rule out 
that these differences also reflect differences in the distribution of cognitive 
paradigms that were employed in the studies included in the adult and 
adolescent meta-analyses. However, it is worth noting that one common region 
of altered activation in relation to cannabis exposure that has emerged in both 
the adult and adolescent meta-analyses is a region that maps close to the angular 
gyrus region an area within the DMN (Andrews-Hanna et al., 2014). This region 
has also been reported to be involved in a number of cognitive processes and is 
thought to serve as a cross-modal hub involved in the integration of information 
from multiple modalities, reorienting attention and retrieving stored 
information in the context of giving meaning to new experiences and problem-
solving (Seghier, 2013). This may reflect the multitude of cognitive tasks 
employed by the various studies included in these meta-analyses, all of which 
involved performing a task thereby requiring the participant to reorient their 
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attention and attempt to solve the problem at hand and suggest that greater 
engagement of this region indicates less efficient cognitive performance in 
cannabis users in general, irrespective of their age. On the other hand, perhaps it 
may also reflect an alteration in the attribution of meaning or significance that 
has been well recognised in the context of cannabis use and experimental 
cannabinoid challenge studies (Bhattacharyya et al., 2015; Bhattacharyya et al., 
2012c; Wijayendran et al., 2016) and in the context of psychotic disorders 
(Kapur, 2003) that are sometimes associated with heavy and long-term use in a 
small proportion of cannabis users (Appiah-Kusi et al., 2016; Moore et al., 2007). 
It is particularly noteworthy that across both the adult and adolescent meta-
analyses, components of the SN showed altered activation, albeit in different 
direction. While in adults, this reflected lesser activation in cannabis users 
relative to controls in particular in the insula, in adolescent cannabis users there 
was an opposite pattern of insular engagement relative to controls.  The insula is 
a core node within the SN and plays a central role in the switching of 
engagement between the task positive (CEN) and the task negative (DMN) states, 
thereby allowing the detection of a salient event (Menon, 2011; Sridharan et al., 
2008). Whether this reflects greater developmental sensitivity of adolescent 
cannabis users leading to a more impaired functioning of the network switching 
process that normally allows efficient allocation of cognitive resources in 
adolescents and the same network switching process going on overdrive in 
adults, as a compensatory mechanism, warrants investigation in future studies.  
Some of the other regions where there was altered activation in cannabis users 
in these meta-analyses also overlap with meta-analytic evidence of altered 
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functional brain activation as indexed using fMRI while performing a number of 
cognitive activation tasks in patients with schizophrenia compared to healthy 
controls. Decreased activation was found in patients with schizophrenia 
compared to controls in MFG and the occipital lobe, as well as increased 
activation in the IFG, STG and SFG, consistent with results reported here. 
Increased activation reported by Minzenberg and colleagues in the insula, an 
area that is part of the SN (Menon, 2015), in patients with schizophrenia is 
however in contrast to the findings from our adult analysis (Minzenberg et al., 
2009) while a similar change as patients was observed in the insula in adolescent 
cannabis users. The STG has been shown to have increased activation in patients 
with schizophrenia and those at high clinical risk of psychosis compared to 
controls, similar to that found in our analysis (Crossley et al., 2009). However, it 
is worth noting that this region does not appear to be reliably found in all studies 
included in the meta-analysis.  
There are certain limitations that are inherent to the meta-analytic integration of 
data, especially in the context of neuroimaging studies. For example, use of only 
reported coordinates as opposed to contrast maps renders neuroimaging meta-
analyses subject to bias as only coordinates significant at a certain threshold (e.g. 
p<0.05) are reported in most published studies. This results in clusters of 
activation with p values that are slightly over the threshold being excluded from 
the meta-analysis. However, we tried to mitigate this issue by also including 
published studies that did not include any significant results. While the use of 
activation maps allow better group comparisons of true activation and avoid the 
limitations of coordinate-based meta-analyses, they are much more challenging 
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in terms of having access to activation maps. Another limitation stems from 
heterogeneity in the studies included. There are many sources of heterogeneity 
in the present meta-analyses, from differences in the duration and severity of 
exposure to cannabis and in length of abstinence prior to scan acquisition as well 
as in comorbid exposure to alcohol, nicotine and other drugs between samples 
included in the various studies, to the different cognitive tasks employed as 
activation paradigms during fMRI. While we carried out sub-group analysis 
focusing on studies employing similar or related cognitive tasks, this was 
possible to only a limited extent and only in adult studies because of lack of 
enough studies investigating a particular cognitive process for any statistical 
integration through meta-analysis to be really meaningful. Further limitations 
relate to differences in methods of data analysis that generated the coordinate 
data and statistical values used for meta-analysis as well as scanner differences 
between studies. Use of other drugs have been controlled for by the majority of 
the studies and a number have made efforts to match participants for tobacco 
use, helping to minimize confounding effects. We also carried out sub-group and 
meta-regression analyses to inform the extent to which some of these potential 
confounders influence the results of the complete group meta-analyses. 
Notwithstanding these limitations, the results of this study have shown stable 
differences in brain activation between cannabis users and controls in both adult 
and adolescent analyses. However, it is worth noting that as the studies included 
in the present meta-analyses did not employ longitudinal multi-point 
assessments, the results of the present meta-analysis are unable to inform the 
extent to which observed group differences are a cause or consequence of 
exposure to cannabis. Future studies need to employ longitudinal design and 
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multi-point assessment in conjunction with detailed matching and accounting for 
potential confounders to allow accurate delineation of the effects of cannabis on 
the human brain in adolescent and adult users. Furthermore, future meta-
analytic endeavours in this area should also investigate using a set of 
conceptually related task-based studies to investigate task-specific regional 
differences, once enough of a body of literature has accumulated to allow 
meaningfully powered analysis. 
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7. Figures and Tables 
 
Figure 1; PRISMA flowchart of search strategy for adult and adolescent meta-analysis.   
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Figure 2; Maps of statistically significant differences in activation between cannabis users and healthy 
controls ( Voxel threshold = p<0.005, peak height threshold: peak SDM-Z < 1, clusters ≥ 10). Areas of  
increased activation in cannabis users compared to controls are depicted in red and areas of decreased 
activation in cannabis users compared to controls are depicted in blue. Left side of the brain is shown on the 
left side of the images. 
A = Adult meta-analysis results  
B = Adolescent meta-analysis results  
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Table 1; Functional magnetic resonance imaging studies involving adult cannabis users and healthy controls included in the meta-analysis. 
Study 
 
 
Task CU 
M/F 
HC  
M/F 
Age of 
CU 
(years) 
Age of 
HC 
(years) 
 
Quantity 
of 
cannabis 
used by 
CU 
Quantity 
of 
cannabis 
used by 
HC 
Time 
between 
scan and 
last 
smoke 
Age of 
onset of 
cannabis 
use for 
CU 
(years) 
Mean 
years of 
cannabis 
use by CU 
fMRI 
activation 
paradigms 
(tasks) 
Results of Whole Brain 
Analysis 
Task 
Performance 
Number of 
task 
comparisons 
Tesla fMRI 
method 
(Abdullaev 
et al., 2010) 
 
Attention 
Network 
Task 
10/4 10/4 19.5 
(0.8) 
(SD) 
19.7 
(1.4) 
(SD) 
71-196 
days per 
year 
0 48 hours 12-16 N/A Executive task; 
Alerting task; 
Orienting task. 
CU>HC RLPFC, 
Supplementary motor 
cortex, Lateral parietal 
cortex; No difference for 
Alerting & Orientation 
task. 
Longer 
reaction time 
for CU. More 
errors made 
for executive 
task. 
3 3T FSL 
 Use 
Generation 
Task 
5/2 5/2 19.6 
(0.9) 
 
20 (0.2) 
(SD) 
71-196 
days per 
year 
0 48 Hours 12-16 N/A Generating 
nouns versus 
reading nouns; 
difficult words 
versus easy 
words. 
CU>HC RVPFC. HC>CU 
ACG to LPFC, L 
temporo-parietal 
cortex; CU>HC ACC, R 
fordital cortex, L Frontal 
Pole & L precuneus. 
N/A 2 3T FSL 
(Smith et 
al., 2011) 
 
Go/NoGo 
Task 
6/4 9/5 19-21 19-21 > 1 joints 
per week 
<4 x per 
year 
>3 hours N/A 4.55 
years 
Press all but X; 
Press X 
No significant 
differences in both tasks 
after including 
covariates. 
No Significant 
difference 
2 1.5T SPM 
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(Chang et 
al, 2006) 
 
Visual- 
Attention 
Task 
9/3 11/8 27.91 
6 3.13 
(SEM) 
30.57 6 
1.83 
(SEM) 
≥5 days 
per week 
N/A 4-24 
hours 
9–20 
 
36–448 
months 
 
Visual 
attention 
CU>HC Small clusters of 
L precuneus, LOLG & L 
limbic uncus. HC>CU 
RFC, R & L dorsal 
parietal and R cerebella. 
No Significant 
difference 
1 4T SPM 
 Visual- 
Attention 
Task 
6/6 11/8 29.63 
6 2.50 
(SEM) 
30.57 6 
1.83 
(SEM) 
≥5 days 
per week 
N/A 0.5 - 156 
months 
12–16 
 
48–276 
months 
 
Visual 
attention 
CU>HC Small clusters in 
the frontal, parital, 
temporal and occipital 
regions. HC>CU MFG, 
SFG, IFG, R dorsal MPL 
& declive. 
No Significant 
Difference 
1 4T SPM 
(Cousijn et 
al., 2012) 
 
Iowa 
Gambling 
Task 
21/1
1 
26/1
5 
21.4 
(2.3) 
(SD) 
18-25 
22.2 
(2.4) 
(SD) 
18-25 
> 10 days 
per month 
<50 
lifetime 
use 
24 hours N/A 2.5 (1.9) 
(SD) 
Win>Loss; 
Loss>Win 
CU>HC ROFC, R insula, 
LSTG; No activation 
difference. 
No Significant 
difference 
2 3T FEAT 
(Gruber, 
Rogowska 
and 
Yurgelun-
Todd, 
2009) 
 
Facial affect 
task 
14/1 14/1 25 
(±8.8) 
 
26 
(±9.0) 
 
4-7 days 
per week 
N/A 12 hours 14.9 
(±2.50) 
 
N/A Veiwing Angry 
Faces; Viewing 
Happy Faces 
CU>HC IFG, R 
precuneus, RF 
paracetral lobe, LSTG, 
cerebellar, RMTG, 
HC>CU LSPL, 
interhemispheric 
precuneus, L cingulate 
Gyrus; CU>HC cerebella, 
HC>CU STG & 
sub.lobular space. 
No 
Performance 
data 
2 3T SPM 
(Heitzeg et 
al., 2015) 
 
Emotional 
arousal 
word task 
12/8 14/6 19.84 
(1.45) 
(SD) 
17-22 
20.51 
(1.26) 
(SD) 
17-22 
>100 time 
(average 
618.12) 
<10 
lifetime 
use 
 
48 hours N/A 13.4 
(2.7)  
(SD) 
Negative 
words; 
Positive 
words. 
HC>CU RMF, 
Dorsolateral SFT, RMTG, 
RSTG, R calcarine 
fissure & Insula; CU>HC 
R Dorsolateral SFG, 
HC>CU RIPL. 
No Significant 
difference 
2 3T SPM 
AC
CE
PT
ED
 M
AN
US
CR
IPT
G. Blest-Hopley, V. Giampietro & S. Bhattacharyya 
 
54 
(King et al., 
2011) 
Checker-
board task 
16/1
4 
16/1
4 
M = 21 
F = 
22.5 
18-45 
M= 23 
F= 24.5 
18-45 
6-7 days 
per week 
N/A 12 hours M= 14.5 
F= 16 
(years) 
 
M= 78 
F= 63 
(months) 
2HZ 
frequency; 
4HZ frequency 
CU>HC SFG, HC>CU LG 
& cuneus; L postcentral 
gyrus, Bi. MFG, RSPG, R 
frontal pole, HC>CU R 
postcentral gyrus, R 
precentral gyrus & L LG. 
None Taken 2 3T FMRIB 
(Kanayama 
et al., 2004) 
Spatial 
working 
memory 
Task 
10/2 6/4 37.9 
(7.4) 
(SD) 
30-55 
27.8 
(7.9) 
(SD) 
5100-
54000 life 
time use 
0 6-36 
hours 
N/A >5000 
lifetime 
use 
Short- delay 
task minus 
perception 
task. 
CU>HC SFG, MFG, IFG, 
RSTG, Bi. ACG. R. 
precentral gyrus, 
caudate & putamen. 
HC>CU MFC. 
No Significant 
difference 
1 1.5T SPM 
(Nestor, 
Hester and 
Garavan, 
2010) 
Monetary 
incentive 
delay task 
12/2 11/3 22.1 ± 
1.2 
(SEM) 
18-40 
23.1 ± 
1.2 
(SEM) 
18-40 
5-7 days 
per week 
3.0 ± 0.6 
lifetime 
use 
 
12-505 
hours 
16.1 ± 0.4 
(SEM) 
6.1 ± 1.1 
(SEM) 
Neutral lose; 
Neutral win; 
Lose 50 cent; 
Save 50 cent; 
Miss 50 cent; 
Win 50 cent. 
CU>HC neutral lose & 
win in no. of regions inc. 
caudate nucleus, 
cingulate, inferior 
frontal & 
parahippocampal gyri. 
HC>CU in L insula 
during lose outcome 
and save 50. 
No 
Significant 
difference 
6 3T AFNI 
(Nestor et 
al., 2008) 
Face-Name 
pairs task 
32/3 29/9 22.3 ± 
0.5 
(SEM) 
22.0 ± 
0.4 
(SEM) 
5-7 days 
per week 
< 10 
lifetimes 
use 
3-686 
hours 
16.5 ± 0.4 
(SEM) 
5.7 ± 0.6 
(SEM) 
Learning 
phase; Recall 
phase. 
HC>CU in RSTG, RSFG, 
LSFG; No difference in 
recall. 
No Significant 
difference 
2 3T AFNI 
(van Hell et 
al., 2010) 
Monetary 
reward task 
13/1 11/2 24 (± 
4.4) 
(SEM)
  
2 4 (± 
2.7)  
(SEM) 
1500-
9700 life 
time use 
range 
N/A 1 week N/A N/A Anticipation; 
Reward. 
CU>HC Bi. MTG, R 
cuneus & R 
parahippocampal gyrus. 
HC>CU Bi. nucleus 
accumbens, caudate 
nucleus, SFG, L 
putamen, RIFG, R 
medial FG & L cingulate 
No Significant 
difference 
2 1.5T SPM 
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 gyrus; CU>HC Bi. 
putamen, R caudate 
nucleus. 
(Wesley, 
Hanlon and 
Porrino, 
2011) 
Iowa 
Gambling 
Task 
9/7 6/10 26.4 
(3.6) 
(SD) 
26.6 
(6.1) 
(SD) 
Mean 29.4 
days per 
month 
<50 
lifetime 
use 
None 
from 
12am 
16.3 (2.1) 
(SD) 
9.6 (4.1) 
(SD) 
Win; Lose No difference in Win; 
HC>CU Bi. MFG, R ACC, 
Precuneus & superior 
parietal lobe, L declive. 
More loss 
events for CU 
2 1.5T SPM 
(Sneider et 
al., 2013) 
Virtual 
Water Maze 
Task 
8/2 11/7 18-30 18-33 ≥5 days 
per week 
<5 
lifetime 
use 
12 hours 15.6 ± 1.2 
(SD) 
4.0 ± 2.4 
(SD) 
(years) 
Retrieval - 
motor control 
HC>CU Bi. IF pars 
triagularis, IF par 
opercularis, MFG. LSFG, 
LSF par orbitalis, R 
pallidum & putamen. 
Longer path 
length, same 
time taken. 
User group 
significantly 
less time to 
move. 
1 3T SPM 
CU = Cannabis Users, HC = Healthy Controls, M = Male, F = Female, WBA = Whole Brain Analysis, T = Tesla R = Right, L = Left, Bi. = Bilateral, (V)PFC = (Ventral) Prefrontal Cortex,  ACG = Anterior 
Cingulate Gyrus, (O)LG = (Occipital) Lingual Gyrus, FC = Frontal Cortex, MFG = Middle Frontal Gyrus, SFG = Superior Frontal Gyrus, IFG = Inferior Frontal Gyrus, OFC, Orbitofrontal Cortex, STG = 
Superior Temporal Gyrus, MTG = Medial Temporal Gyrus, ACC = Anterior Cingulate Cortex, IF = Inferior Frontal, SPL =  Superior Parietal Lobe, MPL = Medial Parietal Lobe, SPG = Superior Parietal 
Gyrus, IPL = Inferior Parietal Lobe, N/A = Quantity not reported in paper, SD = Standard Deviation SEM =Standard error of the mean. 
. 
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Table 2; Functional magnetic resonance imaging studies involving adolescent cannabis users and healthy controls; used in the meta-analysis. 
Study Task CU 
M/F 
HC 
M/F 
Age of 
CU 
(years) 
Age of 
HC 
(years) 
Quantity 
of 
cannabis 
used by 
CU 
Quantity 
of 
cannabis 
used by 
HC 
Time 
between 
scan and 
last smoke 
Age of 
onset of 
cannabis 
use for CU 
(years) 
Average 
years of 
cannabis 
use by CU 
fMRI 
activation 
paradigm
s (tasks) 
Results WBA Task 
Performance 
results 
Number of 
task 
comparisons 
Tesla fMRI 
method 
(Acheson et 
al., 2015) 
Win/Lose 
Gambling 
Task 
11/3 11/3 17.3 
(1.3) 
(SEM) 
 
17.6 
(1.0) 
(SEM) 
>5 uses per 
week 
0 None from 
12am 
N/A N/A Win ; Loss CU>HC MFG, Caudate 7 
Claustrum; CU>HC 
RMFG, R post. &ant. 
Cingulate, L Insula, Bi. 
Claustrum & declive. 
Not Reported 2 3T FSL 
(Behan et 
al., 2014) 
Go/NoGo 
Task 
16/1 17/1 16.5 
(0.2) 
(SEM) 
16.1 
(0.4) 
(SEM) 
42.9 mean 
joints per 
week 
13 mean 
lifetime use 
 
None from 
12am 
13 (0.2) 
(SEM) 
 
N/A Successful 
inhibition 
HC>CU Bi. white matter 
adjacent to anterior 
cingulate. 
CU 
significantly 
worse at 
inhibition 
task. 
1 3T AFNI 
(Jager et 
al., 2013) 
Monetary 
incentive 
delay task 
21 24 17.2 
(1.0) 
(SD) 
16.8 
(1.3) 
(SD) 
224-32,850 
Joints 
<15 
lifetime use 
24 hours 
(Average 
5.1 weeks) 
13.2 (2.3)  
(SD) 
N/A Anticipatio
n; feedback 
No WBA differences 
found. 
No Significant 
Difference 
2 3T SPM AC
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(Lopez-
Larson et 
al., 2012) 
Finger 
Tapping 
22/12 17/7 18.2 
(0.7)  
(SD) 
18.0 
(1.9)  
(SD) 
Mean use 
of 10.3 
joints per 
week 
N/A No set 
abstinence 
period (20 
participants 
used within 
24 hours) 
15.3 (1.4) 
(SD) 
N/A Finger 
taping 
HC>CU R Cingulate 
Gyrus 
Not Reported 1 3T SPM 
(Schweinsb
urg et al., 
2011) 
Verbal 
Encoding 
Task 
27/9 29/9 18.1 
(0.9) 
18.0 
(1.0) 
(SD) 
17.6 
(0.8) 
18.1 
(0.7) 
(SD) 
480.7 
(277.2 SD) 
life time 
use 
 
1.50 (4.68) 
lifetime use 
( two 
groups 
added ) 
117.6 
(153.9) 
days + 43.4 
(37.1) 
14.5 (2.5) 
14.9 (3.4) 
(SD) 
N/A Novel 
encoding 
No significant difference. No Significant 
Difference 
1 3T AFNI 
(Schweinsb
urg et al., 
2008) 
Spatial 
working 
memory 
Task 
11/4 12/5 18.1 
(0.7) 
(SD) 
17.9 
(1.0) 
(SD) 
480.7 
(277.2 SD) 
life time 
use 
0.5 (1.3) 
lifetime use 
 
At least 28 
days 
N/A 4.0 (1.6) 
(SD) 
SWM> 
Viligance; 
Viligance> 
SWM. 
CU>HC R superior 
parietal lobe, HC>CU R 
dorsolateral PFC; 
CU>HC Inferior cuneus. 
No Significant 
Difference 
2 1.5T AFNI 
(Tapert, 
Schweinsb
urg and 
Brown, 
2008) 
Go/NoGo 
Task 
12/4 12/5 18.1 
(0.7)  
(SD) 
17.9 
(1.0) 
(SD) 
475.6 
(268.5 SD) 
life time 
use 
 
<5 lifetime 
use 
28 days 14.0 (1.6)  
 
N/A Inhibition; 
Go 
CU>HC Bi.SFG, 
Bi.MFG, R Insula, Bi. 
MFC, Bi. IPL, Bi. SPL, R 
lingual OG, R middle 
OG; CU>HC RIFG, R 
insula, RSFG, RMFG, 
RSPL, RIPL, R medial 
Precuneus. 
No Significant 
Difference 
2 1.5T AFNI 
CU = Cannabis Users, HC = Healthy Controls, M = Male, F = Female, WBA = Whole Brain Analysis, T = Tesla R = Right, L = Left, Bi. = Bilateral, SFG = Superior Frontal Gyrus, MFG = Middle Frontal Gyrus, 
IFG = Inferior Frontal Gyrus, MFC = Medial Frontal Cortex, IPL = Inferior Parietal Lobe, SPL = Superior Pareital Lobe, OG = Lingual Occipital Gyrus, N/A = Quantity not reported in paper;.SD = Standard 
Deviation SEM =Standard error of the mean  
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Table 3; Functional magnetic resonance imaging of adults and adolescent, meta-analysis results. 
Adults  MNI coordinate SDM-Z P Voxels Area Egger’s Test 
p value 
 x y z      
CU>HC         
 -52 -60 30 1.561 0.00144732 260 L. Superior Temporal Gyrus 0.054 
 54 14 20 1.568 0.001376152 128 R. Inferior Frontal Gyrus 0.141 
 -52 -32 14 1.479 0.002391756 90 L. Posterior Transverse Temporal Gyrus 0.542 
HC>CU         
 -8 -100 -8 -1.843 0.000071228 789 L. Striate area/ Occipital Gyrus 0.989 
 -32 12 -2 -1.637 0.000325918 386 L. Area Piriformis Insulae 0.198 
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 34 -4 54 -1.341 0.002040088 147 R. Middle Frontal Gyrus 0.383 
 32 8 44 -1.278 0.002825022 29 R. Middle frontal Gyrus.  0.232 
Adolescents MNI coordinate SDM-Z P Voxels Label Eggert’s Test p 
value 
 x y z      
CU>HC         
 46 -46 50 1.06 0.00055349 397 R. Inferior Parietal Gyrus 0.283 
 28 14 -2 1.008 0.00083428 348 R. Putamen  0.072 
CU = Cannabis Users, HC = Healthy Controls, R = Right hemisphere, L = Left Hemisphere, SDM = Seed-based D Mapping.  AC
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